Tower Research Capital LLC TRC Increases Stock Position in Waters Co. (NYSE:WAT)

Tower Research Capital LLC TRC raised its position in shares of Waters Co. (NYSE:WATFree Report) by 223.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,222 shares of the medical instruments supplier’s stock after buying an additional 5,683 shares during the period. Tower Research Capital LLC TRC’s holdings in Waters were worth $2,707,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in WAT. Exchange Traded Concepts LLC purchased a new stake in shares of Waters in the 4th quarter worth about $35,000. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Waters in the 3rd quarter worth about $33,000. Wetzel Investment Advisors Inc. purchased a new stake in shares of Waters in the 4th quarter worth about $39,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Waters in the 4th quarter worth about $41,000. Finally, VisionPoint Advisory Group LLC lifted its position in shares of Waters by 300.0% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 108 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Up 0.5 %

NYSE:WAT opened at $302.09 on Friday. The firm has a market cap of $17.92 billion, a P/E ratio of 29.65, a P/E/G ratio of 4.81 and a beta of 0.97. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.30 and a current ratio of 1.94. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $367.21. The firm has a 50-day simple moving average of $326.71 and a two-hundred day simple moving average of $322.85.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.10 by $0.11. The firm had revenue of $636.80 million for the quarter, compared to the consensus estimate of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The business’s quarterly revenue was down 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.49 EPS. Analysts predict that Waters Co. will post 11.85 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

WAT has been the subject of several research analyst reports. Barclays dropped their target price on shares of Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research report on Wednesday, May 8th. Jefferies Financial Group began coverage on shares of Waters in a research note on Monday, June 3rd. They issued a “hold” rating and a $320.00 price target for the company. Robert W. Baird decreased their price target on shares of Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Evercore ISI increased their price target on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research note on Thursday, April 4th. Finally, TD Cowen increased their price target on shares of Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a research note on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating and eleven have given a hold rating to the stock. According to data from MarketBeat, Waters currently has an average rating of “Hold” and an average price target of $307.20.

Read Our Latest Report on Waters

Insider Activity

In other news, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the sale, the director now owns 14,716 shares of the company’s stock, valued at approximately $5,321,894.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Waters news, Director Richard H. Fearon acquired 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The shares were bought at an average price of $332.90 per share, with a total value of $332,900.00. Following the completion of the acquisition, the director now owns 1,653 shares in the company, valued at approximately $550,283.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. Insiders own 0.82% of the company’s stock.

About Waters

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.